# The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure

> **NCT00944229** · PHASE3 · TERMINATED · sponsor: **Columbia University** · enrollment: 58 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** LOVAZA (Omega-3)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00944229
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 58 (ACTUAL)
- **Why stopped:** PI left the institution
- **Last updated:** 2016-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944229, "The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00944229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*